Publication Date
2025
School
School of Health Sciences
Major
Biology: Biomedical Sciences
Keywords
Multiple Sclerosis, Demyelinating Disease, Oligodendrocyte, Glial Cell
Disciplines
Medical Neurobiology | Musculoskeletal, Neural, and Ocular Physiology
Recommended Citation
Williams, Nathaniel Howard, "Perspectives on Demyelinating Disease: An Overview of Multiple Sclerosis" (2025). Senior Honors Theses. 1542.
https://digitalcommons.liberty.edu/honors/1542
Abstract
Multiple sclerosis (MS) is a demyelinating disease of central nervous system (CNS), primarily concerning oligodendrocytes, the myelinating cells of the CNS and the neurons that are ensheathed in myelin. MS is the most common demyelinating disease, affecting as many as 300,000 yearly in the United States alone. Much debate centers on whether MS onset is primarily caused by autoimmune reactions or intrinsic dysfunction in oligodendrocytes, which prompts an immune-mediated response. Those who review the current literature on MS may become quickly overwhelmed by the volume and variety of available material. The purpose of this review is to present a comprehensive overview of MS pathophysiology, to compile research related to established therapies, and to present novel clinical targets for researchers, scientists, and clinicians to consider.
